Tocilizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, ACTPen Autoinjector AUST R: 296808Active ingredients:
Tocilizumab
Dosage form:
Injection, solution
Sponsor:
Roche Products Pty Ltd
Phone:
1800 233 950
|
Deletion from market:
31 May 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product was replaced with a new formulation in May 2024. See ARTG entry 370315.
|
ACTEMRA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe AUST R: 234034Active ingredients:
Tocilizumab
Dosage form:
Injection, solution
Sponsor:
Roche Products Pty Ltd
Phone:
1800 233 950
|
Deletion from market:
31 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Commercial Changes / Commercial viability
Management action:
This product was replaced with a new formulation in August 2024. See ARTG entry 370314.
|